# Safety and Efficacy of MEM 3454 Versus Placebo in Patients With Mild to Moderate Alzheimer's Disease

> **NCT00454870** · PHASE2 · COMPLETED · sponsor: **Memory Pharmaceuticals** · enrollment: 80 (estimated)

## Conditions studied

- Alzheimer's Disease

## Interventions

- **DRUG:** MEM 3454

## Key facts

- **NCT ID:** NCT00454870
- **Lead sponsor:** Memory Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-02
- **Primary completion:** 2007-10
- **Final completion:** 2007-10
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2008-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00454870

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00454870, "Safety and Efficacy of MEM 3454 Versus Placebo in Patients With Mild to Moderate Alzheimer's Disease". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00454870. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*